Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Launched by THOMAS ADVANCED MEDICAL LLC · Dec 22, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of mesenchymal stem cells, which are a type of cell that can help repair and heal the body, for treating various health conditions such as autoimmune diseases, heart problems, diabetes complications, and more. The goal is to see if this stem cell therapy is safe, well-tolerated, and effective for people dealing with these chronic and acute illnesses. The trial is currently recruiting participants who are 18 years or older and can provide informed consent.
If you or a loved one are interested in participating, you will need to be available for follow-up visits and should not have had any active cancer in the past two years, nor be pregnant or breastfeeding. Participants can expect to be monitored closely throughout the study to ensure their safety and to gather important information on how well the treatment works. This trial is an important step in exploring new treatment options for a range of serious health conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 and older
- • Ability to provide informed consent
- • Availability for follow up visits
- Exclusion Criteria:
- • Active or recent malignancy (within last 2 years)
- • Pregnancy or breast-feeding
- • Inability to provide informed consent
About Thomas Advanced Medical Llc
Thomas Advanced Medical LLC is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on enhancing patient outcomes, the company specializes in conducting high-quality clinical trials across a range of therapeutic areas. Leveraging a team of experienced professionals and a robust network of clinical sites, Thomas Advanced Medical LLC is committed to adhering to rigorous regulatory standards and ethical practices. Their mission is to facilitate the effective translation of scientific discoveries into safe and effective medical solutions, ultimately contributing to the advancement of modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Culver City, California, United States
Patients applied
Trial Officials
Ernst R Von Schwarz, MD, PhD
Principal Investigator
HeartStem Institute, Southern California Hospital at Culver City
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials